Cargando…

Adjuvant chemoradiotherapy for locoregionally advanced and high-risk salivary gland malignancies

BACKGROUND: To report the outcomes of patients with locoregionally advanced and high- risk salivary gland malignancies treated with surgery followed by adjuvant chemoradiotherapy. METHODS: From 09/1991 - 06/2007, 24 high-risk salivary gland cancer patients were treated with surgery, followed by adju...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pederson, Aaron W, Salama, Joseph K, Haraf, Daniel J, Witt, Mary Ellen, Stenson, Kerstin M, Portugal, Louis, Seiwert, Tanguy, Villaflor, Victoria M, Cohen, Ezra EW, Vokes, Everett E, Blair, Elizabeth A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189162/ https://www.ncbi.nlm.nih.gov/pubmed/21791072 http://dx.doi.org/10.1186/1758-3284-3-31

Ejemplares similares

Adjuvant treatment for high‐risk salivary gland malignancies and prognostic stratification based on a 20‐year single institution experience
por: Onderdonk, Benjamin E., et al.
Publicado: (2020)

The Role of Prognostic Factors in Salivary Gland Tumors Treated by Surgery and Adjuvant Radio- or Chemoradiotherapy – A Single Institution Experience
por: Kordzińska-Cisek, Izabela, et al.
Publicado: (2020)

Adjuvant Capecitabine Following Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Randomized Clinical Trial
por: Miao, Jingjing, et al.
Publicado: (2022)

Prospective study evaluating dynamic changes of cell-free HPV DNA in locoregional viral-associated oropharyngeal cancer treated with induction chemotherapy and response-adaptive treatment
por: Rosenberg, Ari J., et al.
Publicado: (2022)

DNA Repair Biomarkers XPF and Phospho-MAPKAP Kinase 2 Correlate with Clinical Outcome in Advanced Head and Neck Cancer
por: Seiwert, Tanguy Y., et al.
Publicado: (2014)

Preoperative chemoradiotherapy for locoregional esophageal cancer: preliminary report.
por: Kim, S. B., et al.
Publicado: (1995)

The Clinical Outcomes and Toxicities of Induction Chemotherapy Followed by Concurrent Chemoradiotherapy Plus Adjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
por: Zou, Rui, et al.
Publicado: (2021)

Induction versus adjuvant chemotherapy combined with concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study
por: Mu, Xiaoli, et al.
Publicado: (2022)

Complete response to alectinib in ALK-fusion metastatic salivary ductal carcinoma
por: Adashek, Jacob J., et al.
Publicado: (2023)

Chemoradiotherapy in a Case of Malignant Syringocystadenocarcinoma Papilliferum of Vulva with Locoregional Failure
por: Rao, Pamidimukkala Bramhananda, et al.
Publicado: (2015)

Similarity and difference in tumor-infiltrating lymphocytes in original tumor tissues and those of in vitro expanded populations in head and neck cancer
por: Ren, Lili, et al.
Publicado: (2017)

Adjuvant chemotherapy with S-1 after curative chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck: Reanalysis of the ACTS-HNC study
por: Kubota, Akira, et al.
Publicado: (2018)

Efficacy of adjuvant chemotherapy/maintenance chemotherapy after induction chemotherapy and concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: Experiences of two centers
por: Tao, Hao‐Yun, et al.
Publicado: (2022)

Salivary Gland Scintigraphy in the Evaluation of Salivary Gland Dysfunction
por: Tin, Sim Sai, et al.
Publicado: (2015)

The impact of smoking on the clinical outcome of locoregionally advanced nasopharyngeal carcinoma after chemoradiotherapy
por: Guo, Shan-Shan, et al.
Publicado: (2014)

The Salivary Glands
por: Marini, Geo. C. De
Publicado: (1860)

Salivary Glands
por: Botts, Suzanne, et al.
Publicado: (2018)

Identification of neoantigen-specific T cells and their targets: implications for immunotherapy of head and neck squamous cell carcinoma
por: Ren, Lili, et al.
Publicado: (2019)

Lymphadenoma of the Salivary Glands
por: Tribedi, B. P., et al.
Publicado: (1948)

Salivary gland neoplasms
por: Kamath, Abhay T.
Publicado: (2018)

Tuberculosis of the Salivary Glands
Publicado: (1898)

Tuberculosis of the Salivary Glands
Publicado: (1898)

The Innervation of the Salivary Glands
Publicado: (1882)

The Innervation of the Salivary Glands
Publicado: (1882)

No survival benefit from adding chemotherapy to adjuvant radiation in advanced major salivary gland cancer
por: Kang, Nai-Wen, et al.
Publicado: (2022)

Synergistic locoregional chemoradiotherapy using a composite liposome-in-gel system as an injectable drug depot
por: GuhaSarkar, Shruti, et al.
Publicado: (2016)

Salvage chemoradiotherapy with cisplatin and vinorelbine for postoperative locoregional recurrence of non-small cell lung cancer
por: Hisakane, Kakeru, et al.
Publicado: (2017)

Efficacy and safety of nimotuzumab with neoadjuvant chemotherapy followed by concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma
por: Wang, Fangzheng, et al.
Publicado: (2017)

Comparing treatment outcomes of concurrent chemoradiotherapy with or without nimotuzumab in patients with locoregionally advanced nasopharyngeal carcinoma
por: Yao, Ji-Jin, et al.
Publicado: (2018)

Less is more: role of additional chemotherapy to concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal cancer management
por: Ahn, Yong Chan
Publicado: (2019)

Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy for the treatment of locoregionally advanced nasopharyngeal carcinoma: a retrospective controlled study
por: Qiu, Wen-Ze, et al.
Publicado: (2016)

Heuristic value-based framework for lung cancer decision-making
por: Mambetsariev, Isa, et al.
Publicado: (2018)

The role of adjuvant radiation therapy for locoregionally recurrent papillary thyroid carcinoma
por: Hwang, Hyun, et al.
Publicado: (2021)

Identification of surrogate endpoints in patients with locoregionally advanced nasopharyngeal carcinoma receiving neoadjuvant chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone
por: Chen, Yu-Pei, et al.
Publicado: (2015)

Cytomegalovirus microRNAs Facilitate Persistent Virus Infection in Salivary Glands
por: Dölken, Lars, et al.
Publicado: (2010)

Prolonged response to checkpoint inhibitor therapy in two metastatic mucoepidermoid salivary gland carcinoma cases: a research report
por: Pharaon, Rebecca R., et al.
Publicado: (2022)

Xerophthalmia of Sjogren's Syndrome Diagnosed with Anti-Salivary Gland Protein 1 Antibodies
por: Vishwanath, Sahana, et al.
Publicado: (2014)

Adenoid Cystic Carcinoma of Sublingual Salivary Gland Obstructing the Submandibular Salivary Gland Duct
por: Kumar, Venkata Suneel, et al.
Publicado: (2013)

A benign salivary gland tumor of minor salivary gland mimicking an epithelial malignancy
por: Reddy, Vandana, et al.
Publicado: (2015)

Adjuvant radiation for salivary gland malignancies is associated with improved survival: A National Cancer Database analysis
por: Bakst, Richard L., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_s153a72rrip2o1s0jhi6pbou37